| __timestamp | Amneal Pharmaceuticals, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 13673000 |
| Thursday, January 1, 2015 | 136870000 | 14358000 |
| Friday, January 1, 2016 | 204747000 | 12203000 |
| Sunday, January 1, 2017 | 191938000 | 18125000 |
| Monday, January 1, 2018 | 210451000 | 17071000 |
| Tuesday, January 1, 2019 | 202287000 | 20018000 |
| Wednesday, January 1, 2020 | 190585000 | 32788000 |
| Friday, January 1, 2021 | 209563000 | 44966000 |
| Saturday, January 1, 2022 | 200046000 | 311681000 |
| Sunday, January 1, 2023 | 167778000 | 77707000 |
In pursuit of knowledge
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Lantheus Holdings, Inc. and Amneal Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Amneal Pharmaceuticals consistently allocated a significant portion of its budget to R&D, peaking in 2018 with a 97% increase from 2014. However, a notable decline of 20% was observed in 2023, reflecting potential strategic shifts or market challenges.
Conversely, Lantheus Holdings exhibited a dramatic surge in R&D spending, particularly in 2022, where it skyrocketed by over 2,000% compared to 2014. This substantial increase underscores Lantheus's commitment to innovation and growth.
These trends highlight the dynamic nature of R&D investments and their critical role in shaping the future of pharmaceutical advancements.
Eli Lilly and Company vs Lantheus Holdings, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Novartis AG vs Amneal Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Sanofi and Lantheus Holdings, Inc.
Bristol-Myers Squibb Company or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Genmab A/S vs Amneal Pharmaceuticals, Inc.
Blueprint Medicines Corporation or Lantheus Holdings, Inc.: Who Invests More in Innovation?
Lantheus Holdings, Inc. vs Amneal Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Analyzing R&D Budgets: Grifols, S.A. vs Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Amneal Pharmaceuticals, Inc. vs Geron Corporation
R&D Insights: How Amneal Pharmaceuticals, Inc. and Dynavax Technologies Corporation Allocate Funds
Analyzing R&D Budgets: Amneal Pharmaceuticals, Inc. vs Galapagos NV